Advertisement

Tumor Biology

, Volume 35, Issue 8, pp 7429–7433 | Cite as

Role of ZIC1 methylation in hepatocellular carcinoma and its clinical significance

  • Yan-Ying Wang
  • Jian-Xin Jiang
  • Hong Ma
  • Jie Han
  • Zhi-Yang Sun
  • Zhong-Min Liu
  • Zeng-Guang Xu
Research Article

Abstract

Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies in humans, and its prognosis is generally poor even after surgery. The zinc finger of the cerebellum (ZIC1) gene is a novel tumor suppressor gene that plays a crucial role in vertebrate development. Altered expression of ZIC1 is observed in various types of human cancers. The aims of the present study were to investigate the methylation status of ZIC1 in HCC and evaluate its clinical implication. The methylation status of ZIC1 was analyzed in 132 pairs of HCC and corresponding noncancerous tissues by methylation-specific polymerase chain reaction (PCR) (MSP). The expression of ZIC1 messenger RNA (mRNA) in HCC tissues was examined by real-time PCR. Methylation frequency of ZIC1 in HCC was significantly higher than that in the corresponding noncancerous tissues (P < 0.001), and it was correlated with tumor size (P = 0.022), histological differentiation (P = 0.033), and tumor stage (P = 0.009). The downregulation of the ZIC1 mRNA expression in HCC was correlated with the ZIC1 methylation (P < 0.001). The patients with methylated ZIC1 had a poorer overall survival than those without methylated ZIC1 (P < 0.001). Taken together, our results suggested that the hypermethylation may lead to promoter silencing of ZIC1 mRNA and associated with poor survival in HCC. Overall, aberrant methylation is an important mechanism for ZIC1 inactivation in HCC, and ZIC1 methylation may be a promising biomarker for the diagnosis and prognosis of HCC.

Keywords

ZIC1 Methylation MSP Prognosis 

Notes

Conflicts of interest

None

References

  1. 1.
    Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010;7:448–58. doi: 10.1038/nrgastro.2010.100.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Liu Y, Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect. 2010;118:818–24. doi: 10.1289/ehp.0901388.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264–73. doi: 10.1053/j.gastro.2011.12.061. e1.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415–28. doi: 10.1038/nrg816.PubMedCrossRefGoogle Scholar
  5. 5.
    Nishida N, Goel A. Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics. 2011;12:130–7. doi: 10.2174/138920211795564359.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13:484–92. doi: 10.1038/nrg3230.PubMedCrossRefGoogle Scholar
  7. 7.
    Bergman Y, Cedar H. DNA methylation dynamics in health and disease. Nat Struct Mol Biol. 2013;20:274–81. doi: 10.1038/nsmb.2518.PubMedCrossRefGoogle Scholar
  8. 8.
    Akhavan-Niaki H, Samadani AA. DNA methylation and cancer development: molecular mechanism. Cell Biochem Biophys. 2013;67:501–13. doi: 10.1007/s12013-013-9555-2.PubMedCrossRefGoogle Scholar
  9. 9.
    Aruga J. The role of Zic genes in neural development. Mol Cell Neurosci. 2004;26:205–21.PubMedCrossRefGoogle Scholar
  10. 10.
    Michiels EM, Oussoren E, Van Groenigen M, Pauws E, Bossuyt PM, Voûte PA, et al. Genes differentially expressed in medulloblastoma and fetal brain. Physiol Genomics. 1999;1:83–91.PubMedGoogle Scholar
  11. 11.
    Wong YF, Cheung TH, Lo KW, Yim SF, Siu NS, Chan SC, et al. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene. 2007;26:1971–82. doi: 10.1038/sj.onc.1209986.PubMedCrossRefGoogle Scholar
  12. 12.
    Pourebrahim R, Van Dam K, Bauters M, De Wever I, Sciot R, Cassiman JJ, et al. ZIC1 gene expression is controlled by DNA and histone methylation in mesenchymal proliferations. FEBS Lett. 2007;581:5122–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Gan L, Chen S, Zhong J, Wang X, Lam EK, Liu X, et al. ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer. PLoS ONE. 2011;6:e16916. doi: 10.1371/journal.pone.0016916.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Wang LJ, Jin HC, Wang X, Lam EK, Zhang JB, Liu X, et al. ZIC1 is downregulated through promoter hypermethylation in gastric cancer. Biochem Biophys Res Commun. 2009;379:959–63. doi: 10.1016/j.bbrc.2008.12.180.PubMedCrossRefGoogle Scholar
  15. 15.
    Bosch FX, Ribes J, Cléries R, Díaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9:191–211. v.PubMedCrossRefGoogle Scholar
  16. 16.
    Bosch FX, Ribes J, Borràs J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271–85. doi: 10.1055/s-2007-1007117.PubMedCrossRefGoogle Scholar
  17. 17.
    Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology. 2002;122:1609–19.PubMedCrossRefGoogle Scholar
  18. 18.
    Shin SH, Kim BH, Jang JJ, Suh KS, Kang GH. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array. J Korean Med Sci. 2010;25:1152–9. doi: 10.3346/jkms.2010.25.8.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  1. 1.Research Center for Translational Medicine, East HospitalTongji University School of MedicineShanghaiChina
  2. 2.Department of Gastroenterology, East HospitalTongji University School of MedicineShanghaiChina
  3. 3.Department of Neurosurgery, East HospitalTongji University School of MedicineShanghaiChina
  4. 4.Department of Ultrasonography, East HospitalTongji University School of MedicineShanghaiChina
  5. 5.Department of VIP Ward, East HospitalTongji University School of MedicineShanghaiChina

Personalised recommendations